Pacific Edge NZ$80m Placement and ASX dual listing

  • Cameron Partners advised Pacific Edge in relation to its NZ$80m Placement and ASX dual listing
  • The placement was heavily subscribed with New Zealand, Australian, and global institutional investors participating in the transaction
  • Pacific Edge develops pioneering cancer diagnostics tools and is commercialising its Cxbladder diagnostics product suite in New Zealand, the US, and globally
Read Article